Pregnabit to telemedyczne KTG
do badania dobrostanu płodu,
w dowolnym miejscu i czasie.
Our mission is to support health care professionals, to bring every pregnancy to happy end.
Our story started in 2013, when a personal tragedy inspired our CEO, Patrycja Wizińska-Socha, PhD, to design and introduce a patient friendly, clinical grade, mobile CTG.
The product - Pregnabit - and the platform were ready in 2017 and market launch started at the end of 2017.
Nestmedic is listed on Warsaw Stock Exchange.
Nestmedic’s CEO, Patrycja Wizińska-Socha, was awarded the title of „Innovator of the Year 2016” by MIT Technology Review.
Nestmedic has also received a medicine technology award – a distinction for “the most innovative product at the fair” by the organizer of the International Healthcare Exhibition (WIHE).
Pregnabit device
Pregnabit is a telemedical mobile CTG device registered as medical product in class IIa CE. Pregnabit combines well - known and proven features of a professional cardiotocography machine with the features of modern mobile medical machine.
Pregnabit device uses the following sensors:
Available online through a standard web browser for medical personnel and patients.
The platform contains set of functions to cover all the processes required to provide efficient remote diagnostic for pregnant women in third trimester of pregnancy.
See our video
Why is it worth using the Pregnabit CTG telemedicine system?
Why is it worth using the Pregnabit CTG telemedicine system?